Cystic Fibrosis Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 100 pages | ID: C18BA3B9698EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Cystic Fibrosis Therapeutics in Global, including the following market information:

Global Cystic Fibrosis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cystic Fibrosis Therapeutics market was valued at 5207 million in 2021 and is projected to reach US$ 12190 million by 2028, at a CAGR of 12.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CFTR Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cystic Fibrosis Therapeutics include Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys and Pharmaxis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cystic Fibrosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cystic Fibrosis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cystic Fibrosis Therapeutics Market Segment Percentages, by Type, 2021 (%)

• CFTR
• Mucolytics
• PERT
• Anti-infectives
• Bronchodilators

Global Cystic Fibrosis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cystic Fibrosis Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Cystic Fibrosis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cystic Fibrosis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cystic Fibrosis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cystic Fibrosis Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Vertex Pharmaceuticals
• F. Hoffmann-La Roche
• AbbVie
• Gilead Sciences
• Novartis
• AstraZeneca
• Bayer
• Celtaxsys
• Pharmaxis
• ProQR Therapeutics
• PTC Therapeutics
• Alcresta Therapeutics
• Insmed Incorporated
• Savara
• Cyclacel Pharmaceuticals
• Vectura
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cystic Fibrosis Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cystic Fibrosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYSTIC FIBROSIS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Cystic Fibrosis Therapeutics Market Size: 2021 VS 2028
2.2 Global Cystic Fibrosis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cystic Fibrosis Therapeutics Players in Global Market
3.2 Top Global Cystic Fibrosis Therapeutics Companies Ranked by Revenue
3.3 Global Cystic Fibrosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Cystic Fibrosis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cystic Fibrosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Cystic Fibrosis Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cystic Fibrosis Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cystic Fibrosis Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 CFTR
  4.1.3 Mucolytics
  4.1.4 PERT
  4.1.5 Anti-infectives
  4.1.6 Bronchodilators
4.2 By Type - Global Cystic Fibrosis Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Cystic Fibrosis Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Cystic Fibrosis Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cystic Fibrosis Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Cystic Fibrosis Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Cystic Fibrosis Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Cystic Fibrosis Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cystic Fibrosis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Cystic Fibrosis Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Cystic Fibrosis Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Cystic Fibrosis Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cystic Fibrosis Therapeutics Revenue, 2017-2028
  6.3.2 US Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.3.3 Canada Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Cystic Fibrosis Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cystic Fibrosis Therapeutics Revenue, 2017-2028
  6.4.2 Germany Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.4.3 France Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.4.5 Italy Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.4.6 Russia Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Cystic Fibrosis Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cystic Fibrosis Therapeutics Revenue, 2017-2028
  6.5.2 China Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.5.3 Japan Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.5.6 India Cystic Fibrosis Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cystic Fibrosis Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Cystic Fibrosis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cystic Fibrosis Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.7.3 Israel Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Cystic Fibrosis Therapeutics Market Size, 2017-2028
  6.7.5 UAE Cystic Fibrosis Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Vertex Pharmaceuticals
  7.1.1 Vertex Pharmaceuticals Corporate Summary
  7.1.2 Vertex Pharmaceuticals Business Overview
  7.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Major Product Offerings
  7.1.4 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Vertex Pharmaceuticals Key News
7.2 F. Hoffmann-La Roche
  7.2.1 F. Hoffmann-La Roche Corporate Summary
  7.2.2 F. Hoffmann-La Roche Business Overview
  7.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Key News
7.3 AbbVie
  7.3.1 AbbVie Corporate Summary
  7.3.2 AbbVie Business Overview
  7.3.3 AbbVie Cystic Fibrosis Therapeutics Major Product Offerings
  7.3.4 AbbVie Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 AbbVie Key News
7.4 Gilead Sciences
  7.4.1 Gilead Sciences Corporate Summary
  7.4.2 Gilead Sciences Business Overview
  7.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Major Product Offerings
  7.4.4 Gilead Sciences Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Gilead Sciences Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Cystic Fibrosis Therapeutics Major Product Offerings
  7.5.4 Novartis Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Cystic Fibrosis Therapeutics Major Product Offerings
  7.6.4 AstraZeneca Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 Bayer
  7.7.1 Bayer Corporate Summary
  7.7.2 Bayer Business Overview
  7.7.3 Bayer Cystic Fibrosis Therapeutics Major Product Offerings
  7.7.4 Bayer Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Bayer Key News
7.8 Celtaxsys
  7.8.1 Celtaxsys Corporate Summary
  7.8.2 Celtaxsys Business Overview
  7.8.3 Celtaxsys Cystic Fibrosis Therapeutics Major Product Offerings
  7.8.4 Celtaxsys Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Celtaxsys Key News
7.9 Pharmaxis
  7.9.1 Pharmaxis Corporate Summary
  7.9.2 Pharmaxis Business Overview
  7.9.3 Pharmaxis Cystic Fibrosis Therapeutics Major Product Offerings
  7.9.4 Pharmaxis Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Pharmaxis Key News
7.10 ProQR Therapeutics
  7.10.1 ProQR Therapeutics Corporate Summary
  7.10.2 ProQR Therapeutics Business Overview
  7.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Major Product Offerings
  7.10.4 ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 ProQR Therapeutics Key News
7.11 PTC Therapeutics
  7.11.1 PTC Therapeutics Corporate Summary
  7.11.2 PTC Therapeutics Business Overview
  7.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Major Product Offerings
  7.11.4 PTC Therapeutics Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 PTC Therapeutics Key News
7.12 Alcresta Therapeutics
  7.12.1 Alcresta Therapeutics Corporate Summary
  7.12.2 Alcresta Therapeutics Business Overview
  7.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Major Product Offerings
  7.12.4 Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Alcresta Therapeutics Key News
7.13 Insmed Incorporated
  7.13.1 Insmed Incorporated Corporate Summary
  7.13.2 Insmed Incorporated Business Overview
  7.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Major Product Offerings
  7.13.4 Insmed Incorporated Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 Insmed Incorporated Key News
7.14 Savara
  7.14.1 Savara Corporate Summary
  7.14.2 Savara Business Overview
  7.14.3 Savara Cystic Fibrosis Therapeutics Major Product Offerings
  7.14.4 Savara Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.14.5 Savara Key News
7.15 Cyclacel Pharmaceuticals
  7.15.1 Cyclacel Pharmaceuticals Corporate Summary
  7.15.2 Cyclacel Pharmaceuticals Business Overview
  7.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Major Product Offerings
  7.15.4 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.15.5 Cyclacel Pharmaceuticals Key News
7.16 Vectura
  7.16.1 Vectura Corporate Summary
  7.16.2 Vectura Business Overview
  7.16.3 Vectura Cystic Fibrosis Therapeutics Major Product Offerings
  7.16.4 Vectura Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.16.5 Vectura Key News
7.17 Allergan
  7.17.1 Allergan Corporate Summary
  7.17.2 Allergan Business Overview
  7.17.3 Allergan Cystic Fibrosis Therapeutics Major Product Offerings
  7.17.4 Allergan Cystic Fibrosis Therapeutics Revenue in Global Market (2017-2022)
  7.17.5 Allergan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cystic Fibrosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Cystic Fibrosis Therapeutics Market Drivers in Global Market
Table 3. Cystic Fibrosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Cystic Fibrosis Therapeutics in Global Market
Table 5. Top Cystic Fibrosis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cystic Fibrosis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cystic Fibrosis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cystic Fibrosis Therapeutics Product Type
Table 9. List of Global Tier 1 Cystic Fibrosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cystic Fibrosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cystic Fibrosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cystic Fibrosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cystic Fibrosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cystic Fibrosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cystic Fibrosis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cystic Fibrosis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Vertex Pharmaceuticals Corporate Summary
Table 31. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product Offerings
Table 32. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Corporate Summary
Table 34. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product Offerings
Table 35. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. AbbVie Corporate Summary
Table 37. AbbVie Cystic Fibrosis Therapeutics Product Offerings
Table 38. AbbVie Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Gilead Sciences Corporate Summary
Table 40. Gilead Sciences Cystic Fibrosis Therapeutics Product Offerings
Table 41. Gilead Sciences Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Cystic Fibrosis Therapeutics Product Offerings
Table 44. Novartis Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Cystic Fibrosis Therapeutics Product Offerings
Table 47. AstraZeneca Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Cystic Fibrosis Therapeutics Product Offerings
Table 50. Bayer Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Celtaxsys Corporate Summary
Table 52. Celtaxsys Cystic Fibrosis Therapeutics Product Offerings
Table 53. Celtaxsys Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Pharmaxis Corporate Summary
Table 55. Pharmaxis Cystic Fibrosis Therapeutics Product Offerings
Table 56. Pharmaxis Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. ProQR Therapeutics Corporate Summary
Table 58. ProQR Therapeutics Cystic Fibrosis Therapeutics Product Offerings
Table 59. ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. PTC Therapeutics Corporate Summary
Table 61. PTC Therapeutics Cystic Fibrosis Therapeutics Product Offerings
Table 62. PTC Therapeutics Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Alcresta Therapeutics Corporate Summary
Table 64. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product Offerings
Table 65. Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Insmed Incorporated Corporate Summary
Table 67. Insmed Incorporated Cystic Fibrosis Therapeutics Product Offerings
Table 68. Insmed Incorporated Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Savara Corporate Summary
Table 70. Savara Cystic Fibrosis Therapeutics Product Offerings
Table 71. Savara Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Cyclacel Pharmaceuticals Corporate Summary
Table 73. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product Offerings
Table 74. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Vectura Corporate Summary
Table 76. Vectura Cystic Fibrosis Therapeutics Product Offerings
Table 77. Vectura Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. Allergan Corporate Summary
Table 79. Allergan Cystic Fibrosis Therapeutics Product Offerings
Table 80. Allergan Cystic Fibrosis Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cystic Fibrosis Therapeutics Segment by Type in 2021
Figure 2. Cystic Fibrosis Therapeutics Segment by Application in 2021
Figure 3. Global Cystic Fibrosis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cystic Fibrosis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cystic Fibrosis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2021
Figure 8. By Type - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cystic Fibrosis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cystic Fibrosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AbbVie Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Gilead Sciences Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Celtaxsys Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pharmaxis Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ProQR Therapeutics Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. PTC Therapeutics Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Alcresta Therapeutics Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Insmed Incorporated Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Savara Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Vectura Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Allergan Cystic Fibrosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)